NEWS NAVIGATOR
Englemed logo
SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
ENGLEMED
Contact Englemed
Send an e-mail with your comments!
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
TODAY'S NEWS
Day-time abstention may help combat obesity
Fri May 18th - Regular eating times and fasting for a number of hours a day might prove to be beneficial to our health, a US study has claimed. More
Conflict over diet advice for pregnant women
Fri May 18th - Pregnant women can reduce the risk of developing serious complications by following a calorie controlled diet, researchers say today. More
Athlete pain tolerance could aid treatment
Fri May 18th - Athletes’ ability to tolerate pain for longer than non-athletes could give pain management specialists new ways of treating patients, researchers reported yesterday. More
RECENT COMMENTS
On 11/05/2012 Anonymous wrote:
In fact the biggest risk is the patch and the ring - Read more

On 10/05/2012 Editor wrote:
Welcome to Englemed comments. We'd like your view - Read more

THIS WEEK'S STORIES
New heart medicine drive
Thurs May 17th - People with high cholesterol are being encouraged to take their medicines today as research highlighted the benefits of the medicines. More
Nine new breast cancer genes
Thurs May 17th - Nine new genes have been found linked to breast cancer, British scientists revealed last night. More
Poor food tax plan probed
Wed May 16th - Fatty foods would need a "fat tax" of at least 20 per cent to make a significant difference to the way Britons eat, experts warn today. More
Extra time drug u-turn
Wed May 16th - British regulators today performed a u-turn over a controversial drug - which campaigners say can give men with prostate cancer quality "extra time". More
ENGLEMED HEALTH NEWS

Male hair loss signals later risk

Wednesday February 16th, 2011

Young men who start losing their hair early in life face an increased risk of a male cancer later, researchers warned today.

Experts say the link is likely to indicate the role of some male hormones in triggering the cancer.

Professor Philippe Giraud of the Paris Descartes University, France, and colleagues looked for a potential link, because the male sex hormones called androgens are involved in both male pattern baldness and prostate cancer.

They recruited 669 men: 388 with prostate cancer and 281 without. The participants described their balding pattern at the age of 20, at 30 and at 40. Medical history was taken from the men's doctors.

Those who developed prostate cancer were twice as likely to have begun to go bald at the age of 20, analysis showed. Going bald later on was not associated with prostate cancer risk.

But the team report in Annals of Oncology: "There was no association between early-onset alopecia [male pattern baldness] and an earlier diagnosis of prostate cancer, or with the development of more aggressive tumours."

They add that this population may benefit from routine prostate cancer screening or preventative medication such as finasteride, which is used to treat hair loss and has been shown to decrease prostate cancer risk.

Professor Giraud said: "At present there is no hard evidence to show any benefit from screening the general population for prostate cancer.

"We need a way of identifying those men who are at high risk of developing the disease and who could be targeted for screening and also considered for chemo-prevention using anti-androgenic drugs."

Balding at the age of 20 may be an easily identifiable risk factor, but more research is needed to confirm this.

Yassa, M. et al. Male pattern baldness and the risk of prostate cancer. Annals of Oncology, published online February 16, 2011.

Tags: Cancer | Dermatology | Europe | Men’s Health

Printer friendly page Printer friendly page

CATEGORIES